Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 May 15, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
4 May 12, 2026 FORM 4
3 May 12, 2026 FORM 3
10-Q May 11, 2026 10-Q
8-K May 11, 2026 8-K
SCHEDULE 13G/A May 8, 2026
SCHEDULE 13G/A May 6, 2026
4 Apr 28, 2026 FORM 4
144 Apr 27, 2026
ARS Apr 27, 2026 ARS
DEFA14A Apr 27, 2026 DEFA14A
DEF 14A Apr 27, 2026 DEF 14A
4 Apr 22, 2026 FORM 4
144 Apr 21, 2026
4 Apr 20, 2026 FORM 4
144 Apr 20, 2026
4 Apr 17, 2026 FORM 4
144 Apr 15, 2026
SCHEDULE 13G/A Apr 8, 2026
S-8 Mar 31, 2026 S-8
10-K Mar 30, 2026 10-K
8-K Mar 30, 2026 8-K
4 Mar 26, 2026 FORM 4
← Newer Page 3 of 11 · 263 filings Older →